Lab Member
Ning Jiang, Ph.D.
蒋宁
Position:
Associate Professor
Email:
jiangning@cqmu.edu.cn
Education:
2016 Chongqing Medical University of China, Ph.D.
2013 Chongqing Medical University of China
2008 Chongqing Medical University of China
Research Interest:
Tumor Pathogenesis and Novel Therapeutic Approaches
Publication:
Z Zhang L, Zhou B, Yang J, Ren C, Luo J, Li Z, Liu Q, Huang Z, Wu Z, Jiang N. MTFR2‐Mediated Fission Drives Fatty Acid and Mitochondrial Co‐Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis[J]. Advanced Science, 2025: 2416419.（Co-corresponding author）
Jiao Guo, Wei Zhao, Xinyu Xiao , Shanshan Liu , Liang Liu , La Zhang , Lu Li ,Zhenghang Li , Zhi Li , Mengxia Xu , Qiling Peng , Jianwei Wang , Yuxian Wei , Ning Jiang. Reprogramming exosomes for immunity-remodeled photodynamictherapy against non-small cell lung cancer. Bioactive Materials. 2024,39 (2024): 206-223.（co-corresponding author）
Wei Zhao, La Zhang, Jiao Guo, Qing Xu, Mi Zhang, Hongqing Liu, Cong Ren, Yifan Zhao, Jianwei Wang, Qiling Peng, Ning Jiang. Intelligent Nano‐Cage for Precision Delivery of CRISPR‐Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption[J]. Advanced Functional Materials, 2025: 2418090.（Corresponding author）
Liu S, Xiao X, Zhang L, Wang J, Zhao W, Liu H, Liao R, Li Z, Xu M, Guo J, Zhou B, Du C, Peng Q, Jiang N. Reprogramming Exosomes to Escape from Immune Surveillance for Mitochondrial Protection in Hepatic Ischemia-Reperfusion Injury. Theranostics 2024;14(1):116-13.(co-corresponding author）
Heng-Zhou He, La Zhang, Yi-Lin Wen, Yan-Yang Wang, Jun-Yan Zhang, Fei-Hao Yao, Ji-Yao Yu, Jing-Xian Wu, Qi-Ling Peng, Ning Jiang. Integrating surface‐enhanced Raman scattering with machine learning: Pioneering a comprehensive diagnostic and therapeutic platform for cancer management[J]. Interdisciplinary Medicine, 2025: e20250037.（co-corresponding author）
Li L, Xu Q, Zhang X, Jiang Y, Zhang L, Guo J, Liu H, Jiang B, Li S, Peng Q, Jiang N, Wang J. AIEgen-self-assembled nanoparticles with anti-PD-L1 antibody functionalization realize enhanced synergistic photodynamic therapy and immunotherapy against malignant melanoma[J]. Materials Today Bio, 2025, 30: 101387.（co-corresponding author）
Zhang L, Zhang X, Liu H, Yang C, Yu J, Zhao W, Guo J, Zhou B, Jiang N. MTFR2-dependent mitochondrial fission promotes HCC progression. J Transl Med. 2024 Jan 18;22(1):73.（co-corresponding author）
Zhang X, Li L, Zhang M, Zhang L, Liu S, Guo J, Jiang N, Peng Q, Wang J, Ding S. Intelligent recognition of CTCs from gallbladder cancer by ultrasensitive electrochemical cytosensor and diagnosis of chemotherapeutic resistance[J]. Biosensors and Bioelectronics, 2023: 115183.（co-corresponding author）
Xinyu Xiao, Yu Gao, Shanshan Liu, Meijiao Wang, Min Zhong, Jianwei Wang, Ning Jiang, Qiling Peng. A “nano-courier” for Precise Delivery of Acetylcholine and Melatonin by C5a-targeted Aptamers Effectively Attenuates Reperfusion Injury of Ischemic Stroke[J]. Advanced Functional Materials, 2023.（co-corresponding author）
Liu L, Xiao X, Guo J, Wang J, Liu S, Wang M, Peng Q, Jiang N. Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of Pancreatic Cancer. ACS Appl Mater Interfaces. 2023 Apr 5;15(13):16539-16551.（co-corresponding author）